Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Differentiation of Thyroid Malignancy and Nodular Goiter

NCT04425512 is registered in ClinicalTrials.gov with Kahramanmaras Sutcu Imam University as lead sponsor.

NCT NCT04425512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04425512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Differentiation of Thyroid Malignancy and Nodular Goiter
Lead sponsor
Kahramanmaras Sutcu Imam University
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2014
Completion date
November 1, 2019
Enrollment
333 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

delta neutrophyl index, immature granulocyte count, neutrophyl to lymphocyte ratio, thyroid cancer, thyroid diseases, thyroid nodule